{
    "clinical_study": {
        "@rank": "23235", 
        "arm_group": {
            "arm_group_label": "Aripiprazole", 
            "arm_group_type": "Experimental", 
            "description": "Aripiprazole Immediate Release Once-Daily"
        }, 
        "brief_summary": {
            "textblock": "The goal of the current trial is to determine safety of Once-daily aripiprazole in reducing\n      Total Tic Severity in children and adolescents with Tourette's Disorder."
        }, 
        "brief_title": "Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Tourette's Disorder", 
            "Tic Disorder"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Tic Disorders", 
                "Tics", 
                "Tourette Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Tourette's Disorder is a neuropsychiatric condition that is characterized by the appearance\n      of tics that can be simple or complex in nature. A tic is a sudden, rapid, recurrent,\n      non-rhythmic, stereotyped motor movement or vocalization. There are a very limited number of\n      medications approved for the treatment of Tourette's Disorder. The goal of the current trial\n      is to obtain additional efficacy, safety, and tolerability data in a controlled condition of\n      a Once-daily aripiprazole formulation in children and adolescents with Tourette's Disorder.\n      The trial is a 52-week extension to the double-blind trial.\n\n      The Once-daily tablet formulation that will be evaluated in this trial represents a daily\n      dosage regimen that is intended to be administered to children and adolescents."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Completed participation in Trial 31-12-293\n\n          -  Written ICF obtained from a legally acceptable representative & informed assent at\n             Baseline as applicable by trial center's IRB/IEC\n\n          -  The subject, designated guardian(s) or caregiver(s) are able to comprehend and\n             satisfactorily comply with the protocol requirements, as evaluated by the\n             investigator\n\n        Exclusion Criteria:\n\n          -  Experienced AEs during the double-blind trial (31-12-293) that would, in the\n             investigator's judgment, preclude further exposure to aripiprazole.\n\n          -  The subject had protocol violations during the double-blind trial considered major in\n             the judgment of the investigator which would deem the subject a poor candidate for\n             the trial\n\n          -  A positive drug screen\n\n          -  Sexually active patients not using 2 approved methods of contraception\n\n          -  Females breastfeeding or pregnant (positive blood pregnancy test prior to receiving\n             trial drug)\n\n          -  Risk of committing suicide\n\n          -  Body weight lower than 16 kg\n\n          -  Abnormal laboratory test results, vital signs and ECG results"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "7 Years"
        }, 
        "enrollment": {
            "#text": "111", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01727713", 
            "org_study_id": "31-12-294"
        }, 
        "intervention": {
            "arm_group_label": "Aripiprazole", 
            "description": "Open Label: Once-Daily formulation of aripiprazole flex dose regimine", 
            "intervention_name": "Aripiprazole", 
            "intervention_type": "Drug", 
            "other_name": "Abilify"
        }, 
        "intervention_browse": {
            "mesh_term": "Aripiprazole"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Tourette Syndrome", 
            "Basal Ganglia Diseases", 
            "Brain Diseases", 
            "Central Nervous System Diseases", 
            "Tic Disorders", 
            "Tics", 
            "Movement Disorders", 
            "Mental Disorders", 
            "Aripiprazole"
        ], 
        "lastchanged_date": "May 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Dothan", 
                        "country": "United States", 
                        "state": "Alabama"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Goodyear", 
                        "country": "United States", 
                        "state": "Arizona"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orange City", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wildomar", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norwich", 
                        "country": "United States", 
                        "state": "Connecticut"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bradenton", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orange City", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Waldorf", 
                        "country": "United States", 
                        "state": "Maryland"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bloomfield Hills", 
                        "country": "United States", 
                        "state": "Michigan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mt Arlington", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Summit", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manhasset", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Avon Lake", 
                        "country": "United States", 
                        "state": "Ohio"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orem", 
                        "country": "United States", 
                        "state": "Utah"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norfolk", 
                        "country": "United States", 
                        "state": "Virginia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Petersburg", 
                        "country": "United States", 
                        "state": "Virginia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bellevue", 
                        "country": "United States", 
                        "state": "Washington"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Whitby", 
                        "country": "Canada", 
                        "state": "Ontario"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Szeged", 
                        "country": "Hungary"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Catania", 
                        "country": "Italy"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada", 
                "Hungary", 
                "Italy"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder", 
        "overall_official": {
            "affiliation": "Otsuka Pharmaceutical Development & Commercialization, Inc.", 
            "last_name": "Eva Kohegyi, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Canada: Health Canada", 
                "Hungary: National Institute of Pharmacy", 
                "Italy: Ministry of Health"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Number and percentage of subjects with adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline to Week 52"
            }, 
            {
                "measure": "Number and percentage of subjects with clinically significant abnormal laboratory test results, vitals, and ECGs", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline to Week 52"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01727713"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from Baseline to endpoint on the Total Tic Score (TTS) of the Yale Global Tic Severity Scale(YGTSS)", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 52"
            }, 
            {
                "measure": "The long-term effect of Once-daily aripiprazole measured by the Gilles de la Tourette Syndrome-Quality of Life Scale  (GTS-QOL)", 
                "safety_issue": "No", 
                "time_frame": "Baseline to Week 52"
            }
        ], 
        "source": "Otsuka Pharmaceutical Development & Commercialization, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Otsuka Pharmaceutical Development & Commercialization, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}